A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
出版年份 2016 全文链接
标题
A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
作者
关键词
-
出版物
Annals of Clinical and Translational Neurology
Volume 3, Issue 4, Pages 266-279
出版商
Wiley
发表日期
2016-02-25
DOI
10.1002/acn3.288
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome
- (2014) C.A. Montojo et al. NeuroImage-Clinical
- Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1
- (2013) Florian Mainberger et al. BMC Neurology
- Autism traits in the RASopathies
- (2013) Brigid Adviento et al. JOURNAL OF MEDICAL GENETICS
- Challenges of cognitive research in neurofibromatosis type 1
- (2013) Maria T Acosta LANCET NEUROLOGY
- Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial
- (2013) Thijs van der Vaart et al. LANCET NEUROLOGY
- Power failure: why small sample size undermines the reliability of neuroscience
- (2013) Katherine S. Button et al. NATURE REVIEWS NEUROSCIENCE
- Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study
- (2012) SHRUTI GARG et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Impact of ADHD in Adults With Neurofibromatosis Type 1
- (2012) Victor-Felix Mautner et al. Journal of Attention Disorders
- Lovastatin regulates brain spontaneous low-frequency brain activity in Neurofibromatosis type 1
- (2012) Camille Chabernaud et al. NEUROSCIENCE LETTERS
- Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: Developing Imaging Biomarkers to Enhance Treatment Development for Schizophrenia and Related Disorders
- (2011) Cameron S. Carter et al. BIOLOGICAL PSYCHIATRY
- Lovastatin as Treatment for Neurocognitive Deficits in Neurofibromatosis Type 1: Phase I Study
- (2011) Maria T. Acosta et al. PEDIATRIC NEUROLOGY
- Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service
- (2010) D.G. Evans et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Neurofibromin regulates corticostriatal inhibitory networks during working memory performance
- (2010) C. Shilyansky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning
- (2008) Yijun Cui et al. CELL
- Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1
- (2008) Lianne C. Krab JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases
- (2008) Lianne C. Krab et al. TRENDS IN GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now